3 Respiratory system

Please note, sample information has been entered into Chapters 1 and 2 only and although fairly clinically accurate, it is not guaranteed. The information was entered during April and May 2017 and drugs will have subsequently been randomly added during telephone demonstrations.

• Inhaler Devices
• 3.1 Bronchodilators
• 3.2 Corticosteroids
• 3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors
• 3.4 Antihistamines, hyposensitisation, and allergic emergencies
• 3.5 Respiratory stimulants and pulmonary surfactants
• 3.6 Oxygen
• 3.7 Mucolytics
• 3.8 Aromatic inhalations
• 3.9 Cough preparations
• 3.10 Systemic nasal decongestants
• 3.11 Antifibrotics